Human Allogeneic Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Cerebellar Ataxia: A Case Report

Human Allogeneic Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Cerebellar Ataxia: A Case Report

To date, there is no curable treatment option for non-hereditary degenerative cerebellar ataxia. Here we report the case of a patient with sporadic adult-onset ataxia (SAOA) who underwent allogeneic bone marrow-derived mesenchymal stem cell (MSC) therapy via the intrathecal route. A 60-year-old male...

Full description

Bibliographic Details
Main Authors: Pan-Woo Ko, Sangmin Park, Kyunghun Kang, Yong-Hyun Lim, Sang Ryong Kim, Kyoungho Suk, Kyung Suk Kim, Ho-Won Lee
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Medicina
Subjects:
mesenchymal stem cell therapy
allogeneic
cerebellar ataxia
sporadic adult-onset ataxia
Online Access:https://www.mdpi.com/1648-9144/57/4/334

Internet

https://www.mdpi.com/1648-9144/57/4/334

Similar Items